Little cells, big puzzle: CAR T-cell therapy’s journey from bench to bedside | by PhDs of India | Jan, 2022

PhDs of India
Illustration modified on online content; originally sourced from the MSKCC website.

The success of India’s first Chimeric Antigen Receptor (CAR) T-cell therapy is the newest feather in developing an indigenous personalized treatment for cancer. Researchers at the Indian Institute of Technology, Bombay (IITB) developed this cost-effective way to treat cancer by isolating T cells, a subset of immune cells from the patients, which were modified…

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button